Influence of Sodium Intake in spondyLoarthriTes
NCT06259890 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250
Last updated 2025-07-09
Summary
The aim of the SALT study is to analyze the relationship between dietary sodium intake and disease activity in patients with axial spondyloarthritis (radiographic or non-radiographic) or psoriatic arthritis.
Conditions
- Spondyloarthritis, Axial
- Arthritis, Psoriatic
Interventions
- OTHER
-
measurement of salt intake
measurement of salt intake without intervention
Sponsors & Collaborators
-
French Society of Rheumatology
collaborator OTHER -
Centre Hospitalier Universitaire de Besancon
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-30
- Primary Completion
- 2026-11-30
- Completion
- 2027-05-31
Countries
- France
Study Locations
More Related Trials
-
Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity
NCT03003572 ·Status: RECRUITING
-
Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE)
NCT01261793 ·Status: COMPLETED ·Phase: PHASE3
-
Rituximab Objective Outcome Measures Trial in SLE
NCT03054259 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)
NCT03978520 ·Status: COMPLETED ·Phase: PHASE2
-
Cardiology Prevention in Systemic Lupus Erythematosus (SLE)
NCT00610805 ·Status: WITHDRAWN ·Phase: NA
-
An Adaptive Phase II Study to Evaluate the Efficacy, Pharmacodynamics, Safety and Tolerability of GSK2586184
NCT01777256 ·Status: TERMINATED ·Phase: PHASE2
-
Study Medication Adherence and Its Determinants in Chronic Disease Through the Example of Methotrexate in Chronic Inflammatory Rheumatism
NCT02926560 ·Status: COMPLETED
-
This Project Aims to Understand the Needs of Rheumatologists and Other Specialties in the Care of Patients With SLE
NCT06698900 ·Status: COMPLETED
-
Effect of Simvastatin on Endothelial Function in Premenopausal Women With Systemic Lupus Erythematosus (0733-271)(TERMINATED)
NCT00739050 ·Status: TERMINATED ·Phase: PHASE4
-
Premature Atherosclerosis in Systemic Lupus Erythematosus
NCT04037293 ·Status: UNKNOWN
-
A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus
NCT02391259 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK2586184 and the Effect of Food and Gender
NCT01687309 ·Status: COMPLETED ·Phase: PHASE1
-
Serum IL 26 as a Marker of Disease Activity in SLE
NCT05161988 ·Status: UNKNOWN
-
Anti-CD20 Antibodies for Treatment of SLE-PAH
NCT05828147 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus
NCT03161483 ·Status: COMPLETED ·Phase: PHASE2
-
Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)
NCT03189875 ·Status: COMPLETED
-
Ro60 Expression in Macrophages in Sjogren's Disease
NCT06324968 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Follow-up of the Systemic Lupus Erythematosus Cohort as Part of the Multidisciplinary Consultation at Brest CHRU
NCT06551389 ·Status: RECRUITING
-
A Prospective, Single Arm, Open Label, Proof of Concept Clinical Study of Sulfasalazine in the Treatment of Active Systemic Lupus Erythematosus
NCT06360068 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
NCT00339261 ·Status: COMPLETED
-
The Relation Between Serum Zinc and Lupus Nephritis
NCT06564181 ·Status: NOT_YET_RECRUITING
-
Subgrouping SLE - a New Approach to Understand the Pathogenesis and Improve Treatment
NCT07102030 ·Status: RECRUITING
-
Anti-Carbamylated Protein Antibodies in Psoriatic Arthritis
NCT04173039 ·Status: COMPLETED ·Phase: NA
-
Tolerance and Efficacy of Rituximab in Sjogren's Disease
NCT00740948 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Identification of Serum Level of Glutathione Peroxidase 4
NCT06554392 ·Status: NOT_YET_RECRUITING